Stock Market News

Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs

2022.04.28 14:14

Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs
FILE PHOTO: COVID-19 treatment molnupiravir developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021. Merck & Co Inc/Handout via REUTERS/Fil

By Michael Erman

(Reuters) – Merck & Co posted better-than-expected first-quarter earnings and raised its full-year sales estimate on strength from its top-selling cancer drug Keytruda, human papillomavirus (HPV) vaccine Gardasil and its COVID-19 antiviral pill molnupiravir.

Revenue in the quarter rose 50% from a year ago to $15.9 billion, with most of that growth coming from sales of molnupiravir, which was approved in November. Total sales were more than $1 billion above analyst estimates of $14.7 billion, according to Refinitiv IBES data.

Excluding molnupiravir sales, revenue grew 19% in the quarter.

Merck reported net income of $4.31 billion, or $1.70 a share, for the quarter. Excluding one-time items, the company said it earned $2.14 a share, easily topping analyst estimates of $1.83.

Sales of Merck’s cancer immunotherapy Keytruda rose 23% to $4.8 billion, about $300 million more than analysts had forecast.

Gardasil, which prevents HPV-linked cancers, brought in $1.46 billion in the quarter, around $200 million more than Wall Street estimates, primarily driven by strong demand outside the United States, especially from China, the company said.

Molnupiravir sales were $3.2 billion, topping analyst estimates by around $100 million. The drug was developed with Ridgeback Biotherapeutics.

Enthusiasm for the pill once touted as a potential game changer for treating COVID-19 has waned since it was shown to be about 30% effective in reducing hospitalizations, far lower than a rival antiviral therapy from Pfizer Inc. (NYSE:PFE)

Merck expects $5 billion to $5.5 billion in molnupiravir revenue based on sales of 10 million treatment courses to around 40 countries, Chief Financial Officer Caroline Litchfield said in an interview.

“We have the capacity to supply more to the market and it really depends with what happens with the pandemic. It depends on whether we do see more outbreaks, new variants,” Litchfield said.

Merck raised it 2022 earnings forecast to $7.24 to $7.36 per share on sales of $56.9 billion to $58.1 billion, from its previous view of $7.12 to $7.27 a share on revenue of $56.1 billion to $57.6 billion.

Merck shares, which are up about 10% for the year, closed at $84.41 on the New York Stock Exchange on Wednesday.

Source

Related Articles

Leave a Reply

Back to top button
bitcoin
Bitcoin (BTC) $ 103,181.65 0.08%
ethereum
Ethereum (ETH) $ 2,486.49 6.97%
tether
Tether (USDT) $ 1.00 0.01%
xrp
XRP (XRP) $ 2.42 2.73%
bnb
BNB (BNB) $ 652.43 2.52%
solana
Solana (SOL) $ 172.05 0.27%
usd-coin
USDC (USDC) $ 1.00 0.00%
dogecoin
Dogecoin (DOGE) $ 0.232593 14.01%
cardano
Cardano (ADA) $ 0.812475 4.05%
tron
TRON (TRX) $ 0.261328 0.14%
staked-ether
Lido Staked Ether (STETH) $ 2,486.11 7.00%
sui
Sui (SUI) $ 3.98 1.88%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 103,168.64 0.10%
chainlink
Chainlink (LINK) $ 16.72 4.79%
wrapped-steth
Wrapped stETH (WSTETH) $ 2,984.30 6.56%
avalanche-2
Avalanche (AVAX) $ 24.51 6.07%
stellar
Stellar (XLM) $ 0.306189 3.77%
shiba-inu
Shiba Inu (SHIB) $ 0.000016 5.77%
hedera-hashgraph
Hedera (HBAR) $ 0.211388 5.75%
hyperliquid
Hyperliquid (HYPE) $ 25.19 0.85%
the-open-network
Toncoin (TON) $ 3.37 2.71%
bitcoin-cash
Bitcoin Cash (BCH) $ 420.08 2.76%
usds
USDS (USDS) $ 1.00 0.00%
leo-token
LEO Token (LEO) $ 8.51 2.64%
litecoin
Litecoin (LTC) $ 103.19 4.17%
polkadot
Polkadot (DOT) $ 5.06 6.47%
weth
WETH (WETH) $ 2,482.35 6.76%
monero
Monero (XMR) $ 322.31 3.98%
wrapped-eeth
Wrapped eETH (WEETH) $ 2,649.96 6.86%
bitget-token
Bitget Token (BGB) $ 4.84 8.01%
pepe
Pepe (PEPE) $ 0.000013 8.26%
pi-network
Pi Network (PI) $ 0.738751 2.35%
binance-bridged-usdt-bnb-smart-chain
Binance Bridged USDT (BNB Smart Chain) (BSC-USD) $ 1.00 0.03%
coinbase-wrapped-btc
Coinbase Wrapped BTC (CBBTC) $ 103,136.63 0.07%
ethena-usde
Ethena USDe (USDE) $ 1.00 0.02%
whitebit
WhiteBIT Coin (WBT) $ 30.18 0.45%
uniswap
Uniswap (UNI) $ 6.88 9.22%
bittensor
Bittensor (TAO) $ 450.16 5.55%
near
NEAR Protocol (NEAR) $ 3.05 5.90%
aptos
Aptos (APT) $ 5.77 4.65%
dai
Dai (DAI) $ 1.00 0.01%
aave
Aave (AAVE) $ 224.49 7.22%
ondo-finance
Ondo (ONDO) $ 1.04 3.06%
okb
OKB (OKB) $ 54.90 2.39%
susds
sUSDS (SUSDS) $ 1.05 0.03%
ethereum-classic
Ethereum Classic (ETC) $ 19.92 4.72%
internet-computer
Internet Computer (ICP) $ 5.52 2.30%
blackrock-usd-institutional-digital-liquidity-fund
BlackRock USD Institutional Digital Liquidity Fund (BUIDL) $ 1.00 0.00%
crypto-com-chain
Cronos (CRO) $ 0.10035 1.09%
official-trump
Official Trump (TRUMP) $ 14.27 1.23%